OpGen to Present New Data on the Application of Whole Genome Mapping in Microbial Outbreaks at the American Society for Microbiology 113th General Meeting - See more at: http://opgen.com/news/press-releases#sthash.IZ7mrxlV.dpuf

05.16.13

OpGen Contacts:
Michael Farmer
Director, Marketing
(240) 813-1284 office
mfarmer@opgen.com

Kristie Wallis (Media)
Pure Communications, Inc.
(646) 320-3845

Gaithersburg, Md.—May 16, 2013OpGen, Inc. today announced that new data on the utility and application of its Whole Genome Mapping technology in the public health and health care settings will be highlighted at a company-sponsored symposium and poster presentation during the American Society for Microbiology (ASM) 113th General Meeting. The meeting is being held May 18-21, 2013 at the Colorado Convention Center in Denver. OpGen will be exhibiting at booth #1216 during the conference.

Mike Miller, Ph.D., Associate Director for Laboratory Science (Retired) for the National Center for Emerging and Zoonotic Infectious Diseases, CDC, will present new data on OpGen’s Whole Genome Mapping technology during a poster presentation on Monday, May 19, 2013. The poster titled “Whole Genome Mapping for the Analysis of Bacterial Strains from Foodborne Outbreaks” will highlight the application of the technology in the analysis of food-borne pathogens. The poster provides an overview of the utility of Whole Genome Mapping to quickly analyze and map a multi-state outbreak of Salmonella ser. Typhimurium associated with contaminated peanut products.

Additionally, OpGen will host a symposium titled “Complete, High Resolution Whole Genome Mapping Applications in Public and Health Care Settings” on Sunday, May 19, 2013 at 7 p.m. M.D.T. at the Hyatt Regency in Denver. The symposium will feature presentations by Dr. Miller; Jack A. Gilbert, Ph.D., principal investigator, Hospital Microbiome Project at Argonne National Laboratory; and Bart Weimer, Ph.D., Director, 100K Pathogen Genome Project, Director, BGI@Davis and Director, Genomics Integration Core at West Coast Metabolomics Center at the University of California, Davis.